Series A - Agios Pharmaceuticals
Investment Firm
Overview
Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.
Announced Date
Jul 07, 2008
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Flagship Pioneering
Flagship Pioneering is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.
Third Rock Ventures
Third Rock Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed firm.
ARCH Venture Partners
ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.
Participant Investors
3
Round Details and Background
Agios Pharmaceuticals raised $33000000 on 2008-07-07 in Series A
Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 07, 2008 |  Series A - Agios Pharmaceuticals | 3 | - | 33.0M |
| Apr 26, 2010 | Series B - Agios Pharmaceuticals | 1 | - | 8.8M |
| Nov 17, 2011 | Series C - Agios Pharmaceuticals | 4 | - | 78.0M |
| Dec 23, 2009 | Funding Round - Agios Pharmaceuticals | - | undefined |
Recent Activity
There is no recent news or activity for this profile.